Likewise, expression of ABCG2, associated with drug resistant populations and known to be expressed in NSCLC [65], was found altered both in terms of reduced expression level and pattern of expression, losing its membranous component in favor of a nuclear signal. The gene discussed is ABCG2; the disease is non-small cell lung carcinoma.